TheProfitWatch

BMRN - BioMarin Pharmaceuticals Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
52.16 2.32 (4.44%) -0.03 (-0.06%) -0.12 (-0.21%) 0.15 (0.27%) 0.32 (0.61%) 1.76 (3.33%) --- 0.32 (0.61%)

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
1.25
Diluted EPS:
1.23
Basic P/E:
43.58
Diluted P/E:
44.2886
RSI(14) 1m:
66.3
VWAP:
54.5
RVol:

Events

Period Kind Movement Occurred At

Related News